NDUFA9 and non-small cell lung carcinoma: Our initial bioinformatic analyses, drawing from TCGA and single-cell RNA sequencing data, revealed a significant upregulation of NDUFA9 expression within NSCLC tumor tissues and cancer cell populations, correlating with unfavorable clinicopathological indicators, including advanced pathological T stage, male gender, smoking history, and diminished overall survival.